文章基本信息
- 标题：MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
- 本地全文：下载
- 作者：Jiaofeng Huang ; Weijie Ou ; Mingfang Wang 等
- 期刊名称：Risk Management and Healthcare Policy
- 印刷版ISSN：1179-1594
- 电子版ISSN：1179-1594
- 出版年度：2021
- 卷号：Volume 14
- 页码：491-501
- DOI：10.2147/RMHP.S285880
- 出版社：Dove Medical Press Ltd
- 摘要：Background and Aims :Metabolic associated fatty liver disease (MAFLD) is diagnosed in patients with hepatic steatosis when they have the following three metabolic conditions: obesity/overweight, diabetes and metabolic dysregulation, either alone or in combination. There is no clarity whether subtypes of MAFLD diagnosed by different metabolic conditions carry different levels of risk for intra- and extra-hepatic organs. This study aims to depict the characteristics of these subtypes in a large population. Methods :The data were retrieved from the third National Health and Nutrition Examination Surveys of the United States. The clinical and biochemical features in different MAFLD subtypes were compared. The outcome of interest was significant and advanced fibrosis. Results :Out of 4,087 (31.24%) participants with MAFLD, 1,165 (28.51%) were diagnosed by single metabolic condition, 2,053 (50.23%) by two conditions, and 869 (21.26%) by all three metabolic conditions. With increasing numbers of metabolic conditions, participants tended to be older, were more likely to be female, and had more severe renal impairment and liver fibrosis ( P <0.05). MAFLD patients with a lower number of metabolic conditions were more likely to have excessive alcohol consumption. Among MAFLD with single metabolic condition, those diagnosed by diabetes alone had the highest proportion of advanced fibrosis identified by non-invasive fibrosis models ( P <0.05). Conclusion :More metabolic conditions upon the diagnosis of MALFD indicate higher risk of fibrosis. Patients with MAFLD diagnosed by diabetes alone are more likely to have advanced hepatic fibrosis than those with other metabolic conditions alone. Individualized management is required for MAFLD with different subtypes. © 2021 Huang et al.
- 关键词：NHANES;fibrosis;metabolic associated fatty liver disease;metabolic syndromes;nonalcoholic fatty liver disease
